Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

被引：0
|
作者：
Yu Bin Seo
Jacob Lee
Young Keun Kim
Seung Soon Lee
Jeong-a Lee
Hyo Youl Kim
Young Uh
Han-Sung Kim
Wonkeun Song
机构：
[1] Kangnam Sacred Heart Hospital,Division of Infectious Diseases, Department of Internal Medicine
[2] Hallym University College of Medicine,Department of Internal Medicine
[3] Yonsei University Wonju College of Medicine,Division of Infectious Diseases, Department of Internal Medicine
[4] Hallym University Sacred Heart Hospital,Department of Laboratory Medicine
[5] Hallym University College of Medicine,Department of Laboratory Medicine
[6] Yonsei University Wonju College of Medicine,Department of Laboratory Medicine
[7] Hallym University Sacred Heart Hospital,undefined
[8] Hallym University College of Medicine,undefined
[9] Kangnam Sacred Heart Hospital,undefined
[10] Hallym University College of Medicine,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Extended spectrum; Beta-lactamase; Piperacillin-tazobactam; Cefepime; Ertapenem;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Is Piperacillin-Tazobactam Really Comparable to Carbapenem for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms?
    Wang, Jui-Hsiang
    Lai, Chih-Cheng
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2539 - 2540
  • [22] Diversity of extended-spectrum beta-lactamase-producing Escherichia coli rods
    Zalas-Wiecek, Patrycja
    Bogiel, Tomasz
    Wisniewski, Krzysztof
    Gospodarek-Komkowska, Eugenia
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 214 - 219
  • [23] Antimicrobial resistance and risk factors of urinary tract caused by extended-spectrum beta-lactamase-producing
    Topaloglu, R.
    Er, I.
    Gur, D.
    Dogan, B.
    Bilginer, Y.
    Duzova, A.
    Ozen, S.
    Besbas, N.
    Bakkaloglu, A.
    [J]. PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1596 - 1596
  • [24] Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing Escherichia coli
    Al-Tamimi, Mohammad
    Abu-Raideh, Jumana
    Albalawi, Hadeel
    Shalabi, Marwan
    Saleh, Saiel
    [J]. MICROBIAL DRUG RESISTANCE, 2019, 25 (08) : 1132 - 1141
  • [25] Mycotic aneurysm of the thoracic aorta caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Takahashi, Yosuke
    Tsutsumi, Yasushi
    Monta, Osamu
    Ohashi, Hirokazu
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (01) : 61 - 62
  • [26] Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
    Bielen, Luka
    Likic, Robert
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2019, 6 : 1 - 11
  • [27] Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection
    Ghafourian, Sobhan
    Sekawi, Zamberi
    Neela, Vasanthakumari
    Khosravi, Afra
    Rahbar, Mohammad
    Sadeghifard, Nourkhoda
    [J]. SAO PAULO MEDICAL JOURNAL, 2012, 130 (01): : 37 - 43
  • [28] Is Piperacillin-Tazobactam Really Comparable to Carbapenem for the Treatment of Pyelonephritis Caused by Extended-Spectrum β-Lactamase-Producing Organisms? Reply
    Sharara, Sima L.
    Cosgrove, Sara E.
    Tamma, Pranita D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2540 - 2541
  • [29] Malakoplakia in a patient with complicated urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli
    Lee, Wen-Sen
    Chen, Wei-Yu
    Ou, Tsong-Yih
    Chen, Fu-Lun
    Lin, Yung-Wei
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (03) : 345 - 346
  • [30] Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli-Related Complicated Lower Urinary Tract Infection
    Senol, S.
    Tasbakan, M.
    Pullukcu, H.
    Sipahi, O. R.
    Sipahi, H.
    Yamazhan, T.
    Arda, B.
    Ulusoy, S.
    [J]. JOURNAL OF CHEMOTHERAPY, 2010, 22 (05) : 355 - 357
12345